Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells. - Oligonucleotide Therapeutics Society

Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells.

OTS

Alternative splicing,Splice modulation

July 5, 2020

SHARE

Post Views: 381

Michaels WE, Bridges RJ, Hastings ML.

Nucleic Acids Res. 2020 Jun 10:gkaa490.

Related articles

Subscribe to our Newsletter

Oligonucleotide Therapeutics Society

Oligonucleotide Therapeutics Society

c/o Event Innovations, Inc.
4377 Newport Avenue
San Diego, CA 92107, USA

(619) 795-9458
info@oligotherapeutics.org

Terms & Conditions

Resources

Stay Connected

Search

Subscribe in a reader

© Copyright 2012 – 2022 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing

Username/Email Address:
Password:
Forgot Password | Sign Up

Save Password

First Name *
Last Name *
Username *
Email *
Password *
Confirm Password *
Phone:
Organization Name
Select Sectors

By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

Already have an account? Login

This website uses cookies and third party services. Ok